Lansoprazole
Lansoprazole is a pharmaceutical drug with 113 clinical trials. Currently 4 active trials ongoing. Historical success rate of 89.7%.
Success Metrics
Based on 87 completed trials
Phase Distribution
Phase Distribution
21
Early Stage
12
Mid Stage
63
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.3%
87 of 102 finished
14.7%
15 ended early
4
trials recruiting
113
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis
Clinical Trials (113)
Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis
Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008
Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants
Cardiac Safety of Lansoprazole and Domperidon Combination
The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer
Effect of Proton Pump Inhibitors on Endothelial Function
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 113